HLA Class I allele is associated with a lower risk to develop Post-COVID19 interstitial lung manifestations

R. Falfán-Valencia (Ciudad de México (CDMX), Mexico), I. Buendía-Roldán (Ciudad de México (CDMX), Mexico), E. Ambrocio-Ortiz (Ciudad de México (CDMX), Mexico), H. Aguilar-Durán (Ciudad de México (CDMX), Mexico), L. Chávez-Galán (Ciudad de México (CDMX), Mexico), A. Camarena (Ciudad de México (CDMX), Mexico), G. Pérez-Rubio (Ciudad de México (CDMX), Mexico)

Source: International Congress 2022 – Respiratory inflammation and the pulmonary consequences of COVID-19
Session: Respiratory inflammation and the pulmonary consequences of COVID-19
Session type: Thematic Poster
Number: 4285

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Falfán-Valencia (Ciudad de México (CDMX), Mexico), I. Buendía-Roldán (Ciudad de México (CDMX), Mexico), E. Ambrocio-Ortiz (Ciudad de México (CDMX), Mexico), H. Aguilar-Durán (Ciudad de México (CDMX), Mexico), L. Chávez-Galán (Ciudad de México (CDMX), Mexico), A. Camarena (Ciudad de México (CDMX), Mexico), G. Pérez-Rubio (Ciudad de México (CDMX), Mexico). HLA Class I allele is associated with a lower risk to develop Post-COVID19 interstitial lung manifestations. 4285

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.